Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy

The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5–37) and GBP 1234 (569...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Marks, Michael, Bell, Lucy C K, Jones, Imogen, Rampling, Tommy, Kranzer, Katharina, Morris-Jones, Stephen, Logan, Sarah, Pollara, Gabriele
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312207/
https://ncbi.nlm.nih.gov/pubmed/31603189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz991
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars